Director, Noninvasive Imaging
CVI Program Unit(s):
Cardiovascular Development / Congenital Heart Disease
Biotechnology / Nanomedicine / Imaging
CVI Research Description:
My longstanding interests is in using cardiovascular imaging to investigate left ventricular remodeling. This has involved using Doppler echocardiography in large clinical trials accessing the efficacy of pharmaceutical interventions (ACE inhibitors and beta blockers post infarction) and the role of devices including epicardial and endocardial restraint. More recently I am studying the role of cardiac resynchronization and reverse remodeling with advanced heart failure (MIRACLE, MIRACLE ICD, BLOCK-HF and REVERSE Trials).
I also direct the quantitative echocardiographic core laboratory in a number of additional clinical trials that have involved quantitative imaging.
back to top
Last updated: 01/16/2014
The Trustees of the University of Pennsylvania